Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)
NCT02720523Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of upadacitinib in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Mar 2016; status: completed.
02
Drugs
upadacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02720523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720523.